References:
- Rasmussen HM , et al. Nutrients for the aging eye. Clinical Interventions in Aging 2013; 8:741–748.
- Chader GJ, et al. Preface: The aging eye: normal changes, age-related diseases, and sight-saving approaches. Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF1-4.
- Jia YP, et al. The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. Molecules. 2017 Apr 20;22(4).
- Chew EY on behalf of The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2)Randomized Clinical Trial. JAMA 2013; 309(19):2005- 2015.
- Make Vision a Health Priority! National Eye Institute. Available at: http://www. nei.nih.gov/agingeye. [Accessed February 6, 2014].
- Age-related Macular Degeneration (ARMD) symptoms and treatment. Available at: http://www.patient.co.uk/health/age-relatedmaculardegeneration- leaflet [Accessed February 6, 2014].
- Ambati J, et al. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257–293.
- Zhao ZC, et al. Research progress about the effect and prevention of blue light on eyes. Int J Ophthalmol. 2018 Dec 18;11(12):1999-2003.
- Zhang AC, et al. Omega-3 fatty acids and eye health: Opinions and self-reported practice behaviors of optometrists in Australia and New Zealand. Nutrients. 2020 Apr 22;12(4):1179.
- Data on file. IMS TPM S1M EYE TONICS & VITAMINS. July 2020.
- Impact Rx. Script data – July 2020.
Scheduling status: S0 Proprietary name and dosage form: Ocuvite Complete soft gel capsules. Composition: Each soft gel capsule contains fish oil rich in DHA 507,7 mg: of which DHA 180 mg and total omega-3 300 mg, Lutein 5 mg, zeaxanthin 1 mg, vitamin C 90 mg, vitamin E 15 mg, zinc 7,5 mg.
Scheduling status: S0 Proprietary name and dosage form: Ocuvite Lutein tablets. Composition: Each tablet contains Lutein 6 mg, Zeaxanthin 0,5 mg, Vitamin E 8,8 mg, Vitamin C 60 mg, Zinc 5 mg and 20 μg Selenium.
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. For full prescribing information, refer to the Professional Information. Bausch & Lomb Incorporated. ®/™ denote trademarks of Bausch & Lomb Incorporated. Applicant: Soflens (Pty) Ltd. Reg. No.: 1968/011787/07. 254 Hall Street, Centurion, 0157. Tel: +27 10 025 2100. www.bausch.co.za BL481/20
